Cargando…
The cargo protein MAP17 (PDZK1IP1) regulates the immune microenvironment
Inflammation is a complex defensive response activated after various harmful stimuli allowing the clearance of damaged cells and initiating healing and regenerative processes. Chronic, or pathological, inflammation is also one of the causes of neoplastic transformation and cancer development. MAP17...
Autores principales: | García-Heredia, José M., Carnero, Amancio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716752/ https://www.ncbi.nlm.nih.gov/pubmed/29228712 http://dx.doi.org/10.18632/oncotarget.21651 |
Ejemplares similares
-
Efficacy of bortezomib in sarcomas with high levels of MAP17 (PDZK1IP1)
por: Perez, Marco, et al.
Publicado: (2016) -
Sarcoma stratification by combined pH2AX and MAP17 (PDZK1IP1) levels for a better outcome on doxorubicin plus olaparib treatment
por: Perez, Marco, et al.
Publicado: (2020) -
MAP17 (PDZK1IP1) and pH2AX are potential predictive biomarkers for rectal cancer treatment efficacy
por: Rivero, Maria, et al.
Publicado: (2018) -
Dr. Jekyll and Mr. Hyde: MAP17’s up-regulation, a crosspoint in cancer and inflammatory diseases
por: García-Heredia, José M., et al.
Publicado: (2018) -
MAP17, a ROS-dependent oncogene
por: Carnero, Amancio
Publicado: (2012)